Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis
Moran Hellerman Itzhaki, Noam Greenberg, Ili Margalit, Tzippy Shochat, Ilan Krause, Elad Goldberg
DOI: 10.1136/jim-2020-001497 Published 5 August 2021
Moran Hellerman Itzhaki
1Department of General Intensive Care, Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Noam Greenberg
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
Ili Margalit
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
4Infectious Disease Unit, Rabin Medical Center, Beilnson Hospital, Petah Tikva, Israel
Tzippy Shochat
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
5Statistical Consulting Unit, Rabin Medical Center, Beilnson Hospital, Petah Tikva, Israel
Ilan Krause
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
6Department of Internal Medicine F- Recanati, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
Elad Goldberg
1Department of General Intensive Care, Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
No eLetters have been published for this article.
Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis
Moran Hellerman Itzhaki, Noam Greenberg, Ili Margalit, Tzippy Shochat, Ilan Krause, Elad Goldberg
Journal of Investigative Medicine Aug 2021, jim-2020-001497; DOI: 10.1136/jim-2020-001497
Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis
Moran Hellerman Itzhaki, Noam Greenberg, Ili Margalit, Tzippy Shochat, Ilan Krause, Elad Goldberg
Journal of Investigative Medicine Aug 2021, jim-2020-001497; DOI: 10.1136/jim-2020-001497
Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis
Moran Hellerman Itzhaki, Noam Greenberg, Ili Margalit, Tzippy Shochat, Ilan Krause, Elad Goldberg
Journal of Investigative Medicine Aug 2021, jim-2020-001497; DOI: 10.1136/jim-2020-001497